Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Idexx Laboratories Q2 fiscal report highlights growth

Idexx Laboratories Q2 fiscal report highlights growth

26th July 2011

Idexx Laboratories has seen a better-than-expected business performance in the second quarter of 2011.

The animal health company's revenue total for the last three months came to $317.9 million (194 million pounds), a year-on-year rise of 13 percent, while earnings per diluted share saw a 34 percent jump.

According to chairman and chief executive officer Jonathan Ayers, Idexx has been able to advance its strategic and operational initiatives, with market response to the ProCyte Dx haematology analyser noted as a particular highlight.

He also expressed satisfaction with the ten percent organic revenue growth rate experienced by its global reference laboratory and consulting services business.

Mr Ayers said the results "demonstrate our continued success in bringing innovative products and services to our veterinary and other customers, as well as strong commercial execution in markets around the world".

Earlier this month, the company announced plans to create a new corporate administrative facility in the US for a cost of $60 million.ADNFCR-8000103-ID-800634620-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.